Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 601 - 700
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
601 | 25109340 |
US |
19 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
602 | 25109362 |
US |
66 | 1 |
Skin ulcer, Pruritus, |
||||
DUPILUMAB, |
||||
603 | 25109369 |
US |
75 | 2 |
Dry skin, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
604 | 25109388 |
US |
19 | 2 |
Injection site bruising, Dermatitis atopic, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
605 | 25109477 |
US |
33 | 2 |
Pruritus, Rash, |
||||
DUPILUMAB, ALPRAZOLAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TERBINAFINE HYDROCHLORIDE 1G IN 100G, EPINEPHRINE, ADRENALINUM, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, PIMECROLIMUS, HYDROCORTISONE BUTYRATE, |
||||
606 | 25109491 |
KR |
||
Paraesthesia, Mental impairment, Depression, Anxiety disorder, Decreased appetite, Pruritus, Skin disorder, |
||||
OSIMERTINIB, |
||||
607 | 25109553 |
US |
43 | 1 |
Injection site rash, Injection site reaction, Rash, Pruritus, Mental status changes, General physical condition abnormal, |
||||
DUPILUMAB, |
||||
608 | 25113892 |
62 | 2 | |
Pruritus, Rash, |
||||
EVOLOCUMAB, BUPROPION HYDROCHLORIDE, QUETIAPINE, CLONAZEPAM, IXEKIZUMAB, NIACIN, |
||||
609 | 25107684 |
BR |
28 | 2 |
Pruritus, Face oedema, Malaise, Rash, Urticaria, Hyperhidrosis, Dry skin, Fungal skin infection, Onychomycosis, Eczema, Seborrhoea, Alopecia, Upper respiratory tract infection, Lower respiratory tract infection, Pneumonia, Dyspnoea, Sinusitis, Pleurisy, Pulmonary oedema, Chest pain, Oedema, Hot flush, Pain, Chills, Musculoskeletal stiffness, Off label use, |
||||
INFLIXIMAB-AXXQ, PROMETHAZINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
610 | 25107694 |
GB |
46 | 2 |
Liver disorder, Pruritus, |
||||
TERIFLUNOMIDE, |
||||
611 | 25107752 |
US |
79 | 1 |
Pruritus, Product dose omission issue, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, RITUXIMAB, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FINASTERIDE, PRASTERONE, ICOSAPENT ETHYL, ALENDRONATE SODIUM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, ROSUVASTATIN CALCIUM, TESTOSTERONE CYPIONATE, ACYCLOVIR, MONTELUKAST SODIUM, MONTELUKAST, THYROID, PORCINE, ALENDRONATE SODIUM, |
||||
612 | 25107773 |
US |
56 | 1 |
Skin irritation, Pruritus, Insomnia, |
||||
DUPILUMAB, DOXAZOSIN MESYLATE, FISH OIL, FLUTICASONE PROPIONATE, CARVEDILOL, LOSARTAN POTASSIUM, LOSARTAN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ALLOPURINOL, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, UREA, CREAM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREGABALIN, |
||||
613 | 25107781 |
US |
55 | 2 |
Eczema, Pruritus, Dry skin, Rash, Ocular hyperaemia, |
||||
DUPILUMAB, |
||||
614 | 25107791 |
US |
73 | 2 |
Pruritus, Skin fissures, Skin haemorrhage, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, OIL, BIOTIN, HAIR, CALCIPOTRIENE, CETIRIZINE HCL, CETIRIZINE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, FERROUS SULFATE, FLUTICASONE PROPIONATE, FOLIC ACID, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FLUTICASONE PROPIONATE AND SALMETEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LANSOPRAZOLE, PREDNISONE, PREGABALIN, SERTRALINE HYDROCHLORIDE, |
||||
615 | 25107805 |
US |
85 | 2 |
Eczema, Pruritus, Scratch, |
||||
DUPILUMAB, DUPILUMAB, |
||||
616 | 25107809 |
US |
86 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
617 | 25107810 |
US |
40 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
618 | 25107813 |
US |
11 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
619 | 25107821 |
US |
42 | 2 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
620 | 25107826 |
US |
1 | |
Skin disorder, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, AMLODIPINE BESYLATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FAMOTIDINE, LORAZEPAM, ERGOCALCIFEROL, |
||||
621 | 25107845 |
US |
48 | 2 |
Pruritus, Erythema, Sleep disorder due to a general medical condition, Skin atrophy, Sticky skin, Pain in extremity, |
||||
DUPILUMAB, |
||||
622 | 25107869 |
US |
3 | 1 |
Sleep disorder due to a general medical condition, Dermatitis atopic, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
623 | 25107876 |
US |
18 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
624 | 25107894 |
US |
66 | 2 |
Sleep disorder due to a general medical condition, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
625 | 25107896 |
US |
50 | 2 |
Skin irritation, Pruritus, |
||||
DUPILUMAB, |
||||
626 | 25107899 |
US |
2 | |
Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
627 | 25107914 |
US |
2 | |
Depression, Sleep disorder, Pruritus, |
||||
DUPILUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
628 | 25107962 |
US |
72 | 2 |
Pruritus, Eye pruritus, |
||||
DUPILUMAB, |
||||
629 | 25107972 |
US |
38 | 2 |
Pruritus, Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
630 | 25107978 |
US |
15 | 2 |
Dermatitis atopic, Rash, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
631 | 25108002 |
US |
64 | 1 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
632 | 25108006 |
US |
44 | 1 |
Malaise, Diarrhoea, Eczema, Rash papular, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
633 | 25108010 |
US |
37 | 2 |
Pruritus, Injection site erythema, |
||||
DUPILUMAB, |
||||
634 | 25108013 |
US |
5 | 2 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
635 | 25108019 |
US |
57 | 1 |
Dry skin, Pruritus, Dry eye, |
||||
DUPILUMAB, |
||||
636 | 25108041 |
US |
2 | |
Rash, Erythema, Pruritus, |
||||
DUPILUMAB, DOXYCYCLINE HYCLATE, SPIRONOLACTONE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
637 | 25108047 |
US |
39 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, BACLOFEN, |
||||
638 | 25108067 |
US |
32 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
639 | 25108075 |
US |
4 | 2 |
Rash, Pruritus, |
||||
DUPILUMAB, |
||||
640 | 25108164 |
US |
28 | 1 |
Rash papular, Skin irritation, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
641 | 25108194 |
US |
76 | 2 |
Alopecia, Hypertension, Fall, Eye infection, Pruritus, Therapeutic response shortened, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
642 | 25108198 |
US |
68 | 2 |
Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
643 | 25108217 |
US |
78 | 2 |
Sleep disorder due to general medical condition, insomnia type, Pruritus, Rash pruritic, Condition aggravated, Asthenia, Gait disturbance, |
||||
DUPILUMAB, DUPILUMAB, |
||||
644 | 25108225 |
US |
39 | 2 |
Dry mouth, Feeling abnormal, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
645 | 25108254 |
US |
10 | 2 |
Sleep disorder due to a general medical condition, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
646 | 25108265 |
US |
1 | |
Acne, Discomfort, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
647 | 25108296 |
US |
1 | |
Eczema, Pruritus, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
648 | 25108334 |
US |
70 | 2 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
649 | 25108354 |
US |
76 | 2 |
Dry skin, Swelling, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
650 | 25108365 |
US |
2 | |
Pruritus, |
||||
DUPILUMAB, |
||||
651 | 25108393 |
US |
51 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
652 | 25108463 |
CA |
||
Psoriasis, Pruritus, Therapeutic response changed, |
||||
USTEKINUMAB-STBA, USTEKINUMAB-STBA, |
||||
653 | 25108578 |
US |
11 | 1 |
Dry skin, Sleep disorder due to a general medical condition, Pruritus, Incorrect product administration duration, |
||||
DUPILUMAB, |
||||
654 | 25108586 |
US |
63 | 1 |
Sleep disorder due to a general medical condition, Neurodermatitis, Rash, Pruritus, Skin fissures, Skin haemorrhage, Skin weeping, Scratch, Dry skin, |
||||
DUPILUMAB, |
||||
655 | 25108594 |
US |
2 | |
Erythema, Pruritus, |
||||
BIMATOPROST, |
||||
656 | 25108637 |
BR |
||
Depressed level of consciousness, Neutropenia, Infusion related reaction, Hypotension, Dizziness, Malaise, Pruritus, Rash, Overdose, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, LOSARTAN, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, SIMVASTATIN, FINASTERIDE, FLUDARABINE PHOSPHATE, |
||||
657 | 25108676 |
US |
2 | |
Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
658 | 25108713 |
US |
60 | 2 |
Neurodermatitis, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, PROGESTERONE, TRETINOIN, COLESEVELAM HYDROCHLORIDE, ROSUVASTATIN, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, SPIRONOLACTONE, TELMISARTAN, TIRZEPATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ATOGEPANT, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METRONIDAZOLE, |
||||
659 | 25108793 |
US |
17 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
660 | 25108891 |
US |
17 | 1 |
Pruritus, Skin fissures, Dry skin, Skin disorder, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MOMETASONE FUROATE, |
||||
661 | 25109013 |
US |
20 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
662 | 25109080 |
US |
37 | 2 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
663 | 25109106 |
US |
19 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, METHYLPHENIDATE HYDROCHLORIDE, |
||||
664 | 25109148 |
US |
11 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
665 | 25102510 |
US |
2 | |
Influenza, Pruritus, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
666 | 25102547 |
US |
15 | 2 |
Rebound eczema, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, HYDROXYZINE, |
||||
667 | 25102549 |
US |
74 | 1 |
Paraesthesia, Pain in extremity, Pruritus, Hypoaesthesia, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
668 | 25102564 |
US |
1 | |
Pruritus, Eczema, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
669 | 25102640 |
US |
||
Dyspnoea, Bronchiectasis, Pruritus, |
||||
ACALABRUTINIB, |
||||
670 | 25102792 |
US |
80 | 1 |
Eye pruritus, Lacrimation increased, Eye pain, Head and neck cancer, Contusion, Cardiac ventricular thrombosis, Monoparesis, Dermatitis atopic, Pruritus, Ocular rosacea, Eczema, |
||||
APIXABAN, DUPILUMAB, DUPILUMAB, |
||||
671 | 25102813 |
JP |
8 | 2 |
Paraesthesia, Pruritus, Taste disorder, Malignant neoplasm progression, |
||||
ENFORTUMAB VEDOTIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
672 | 25102911 |
JP |
2 | |
Angioedema, Tinnitus, Insomnia, Treatment noncompliance, Abdominal pain, Headache, Eczema, Pruritus, Pain in extremity, Frequent bowel movements, |
||||
MACITENTAN, SELEXIPAG, WARFARIN, TADALAFIL, |
||||
673 | 25102942 |
US |
||
Pruritus, Herpes zoster, |
||||
UPADACITINIB, |
||||
674 | 25103046 |
CN |
58 | 1 |
Rash, Pruritus, Skin exfoliation, Skin injury, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
675 | 25103117 |
US |
63 | 2 |
Rash, Peripheral swelling, Swelling face, Pruritus, Off label use, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
676 | 25103299 |
CA |
48 | 2 |
Anaphylactic reaction, Throat tightness, Pruritus, Blood pressure increased, Heart rate increased, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
677 | 25103380 |
GB |
2 | |
Deafness, Pruritus, Nasopharyngitis, Blood pressure decreased, Epilepsy, |
||||
RISANKIZUMAB-RZAA, |
||||
678 | 25103407 |
GB |
78 | 2 |
Peripheral swelling, Discharge, Pruritus, |
||||
PREGABALIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MORPHINE, MIRTAZAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
679 | 25103477 |
IT |
2 | |
Dysentery, Aerophagia, Dysgeusia, Retching, Palpitations, Pruritus, Pain in extremity, Malaise, Gastrooesophageal reflux disease, Dizziness, Nausea, Vomiting, Flatulence, Off label use, |
||||
ROSUVASTATIN, BISOPROLOL FUMARATE, LANSOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
680 | 25103987 |
US |
2 | |
Product dose omission issue, Product dose omission in error, Fatigue, Flatulence, Abdominal discomfort, Flushing, Pruritus, Rash, Diarrhoea, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, LOPERAMIDE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
681 | 25104022 |
US |
78 | 2 |
Eye swelling, Urticaria, Pruritus, |
||||
IOHEXOL, |
||||
682 | 25104040 |
JP |
75 | 1 |
Dermatitis bullous, Pain of skin, Oedema peripheral, Skin erosion, Platelet count decreased, Skin ulcer, Skin exfoliation, Rash erythematous, Cellulitis, Pruritus, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, VALSARTAN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DUTASTERIDE, |
||||
683 | 25104140 |
US |
52 | 2 |
Eczema, Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
684 | 25104505 |
CA |
78 | 1 |
Death, Fatigue, Pruritus, Rash, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
685 | 25104657 |
US |
45 | 2 |
Urticaria, Pruritus, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
686 | 25104718 |
CN |
16 | 2 |
Epidermolysis bullosa, Drug eruption, Mouth ulceration, Pruritus, |
||||
OXCARBAZEPINE, |
||||
687 | 25104878 |
GB |
69 | 2 |
Swollen tongue, Pruritus, |
||||
CLARITHROMYCIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CITALOPRAM, CITALOPRAM HYDROBROMIDE, NITROGLYCERIN, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BISOPROLOL FUMARATE, RAMIPRIL, |
||||
688 | 25104915 |
CA |
65 | 1 |
Toxic epidermal necrolysis, Pruritus, Rash, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EMPAGLIFLOZIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, RISEDRONATE SODIUM, ROSUVASTATIN, |
||||
689 | 25105025 |
US |
1 | |
Blindness, Burning sensation, Scratch, Pruritus, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, APIXABAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, |
||||
690 | 25105038 |
US |
2 | |
Pruritus, Rash, Infusion related reaction, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
691 | 25105081 |
PT |
48 | 1 |
Abdominal discomfort, Pruritus, Pruritus, Rash, |
||||
IRINOTECAN HYDROCHLORIDE, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, |
||||
692 | 25105240 |
US |
||
Pruritus, |
||||
693 | 25105249 |
PT |
79 | 2 |
Papule, Pruritus, Erythema, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, BISOPROLOL FUMARATE, TELMISARTAN, |
||||
694 | 25105313 |
GB |
2 | |
Skin reaction, Urticaria, Pruritus, Skin burning sensation, Paraesthesia, Dermatitis, Precancerous skin lesion, Blister, Skin irritation, Rash, |
||||
LATANOPROST, LEVOTHYROXINE, LISINOPRIL, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, |
||||
695 | 25105455 |
US |
1 | |
Rash, Pruritus, |
||||
AXITINIB, PEMBROLIZUMAB, |
||||
696 | 25105485 |
US |
61 | 2 |
Ageusia, Tongue haemorrhage, Hypoaesthesia oral, Chromaturia, Pruritus, Off label use, |
||||
SULFASALAZINE, FOLIC ACID, |
||||
697 | 25105566 |
US |
66 | 2 |
Pruritus, Lip swelling, |
||||
BEMPEDOIC ACID, CALCIUM, |
||||
698 | 25105865 |
DE |
68 | 1 |
Dizziness, Ill-defined disorder, Sensory disturbance, Dysstasia, Alopecia, Pruritus, Dry skin, |
||||
CARBOPLATIN, ATEZOLIZUMAB, ATEZOLIZUMAB, ETOPOSIDE, |
||||
699 | 25105939 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Walking aid user, Spinal fusion surgery, Hip arthroplasty, Crohn^s disease, Rheumatoid arthritis, Rheumatoid factor positive, Retinitis, Bronchitis, Laryngitis, Ear infection, Nasopharyngitis, Sinusitis, Folliculitis, Upper respiratory tract infection, Infection, Helicobacter infection, Pneumonia, Wound infection, Breast cancer stage III, Prescribed underdose, Prescribed overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
700 | 25105971 |
US |
83 | 1 |
Herpes zoster, Pruritus, |
||||
APIXABAN, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28